News Daily News Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms Michael O'Riordan April 02, 2021
News Features Roughly 80% of ESC Guideline Writers Have Financial COIs Michael O'Riordan April 01, 2021
News Daily News High Glycemic Index Diets Linked to CVD and Mortality Michael O'Riordan February 24, 2021
News Daily News Despite COVID-19, Heart Disease Remains Top US Killer: AHA Michael O'Riordan January 28, 2021
News Daily News FDA Approves Vericiguat for High-risk Patients With HF Michael O'Riordan January 20, 2021
News Opinion Editor's Corner Envision Change: A Different Future for Cardiology, Medicine, Research, and Health Shelley Wood December 29, 2020
News Features Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good Todd Neale December 14, 2020
News Conference News PCR London Valves 2020 Next-Gen MitraClip Performs as Well as Earlier Device in COAPT: EXPAND Michael O'Riordan November 25, 2020
News Conference News AHA 2020 One in Five Patients Admitted With COVID-19 Die in the Hospital Michael O'Riordan November 20, 2020
News Conference News AHA 2020 Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials Michael O'Riordan November 17, 2020
News Daily News CMS Weighs Medicare Coverage at the Time of FDA Approval for Breakthrough Devices Michael O'Riordan October 30, 2020
News Conference News TCT 2020 MitraClip Viable in MI Patients With Acute MR, Including Patients in Shock: IREMMI Michael O'Riordan October 17, 2020
News Conference News TCT 2020 MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant? Shelley Wood October 16, 2020
News Daily News TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths Michael O'Riordan September 30, 2020
News Daily News VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks Michael O'Riordan September 24, 2020
News Conference News ESC 2020 COVID-19 Blamed for Weaker Research Published by Top-Tier Journals in 2020 Michael O'Riordan September 04, 2020
News Conference News ESC 2020 Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF Michael O'Riordan August 31, 2020
News Conference News ESC 2020 EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class Michael O'Riordan August 29, 2020
News Conference News ESC 2020 EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF Michael O'Riordan August 28, 2020
News Daily News ‘Message Unchanged,’ Say Researchers of Criticized COVID-19 CMR Study Michael O'Riordan August 26, 2020